.png)
_edited.png)
Stem Cell Therapy for Ankle Arthritis: An Option Before Fusion
Quick answer: Cell therapy (MFAT) uses your own microfragmented adipose tissue, prepared and injected the same day under ultrasound guidance. It is a cash-pay, nonsurgical option we offer in Raleigh & Cary for selected joint and tendon problems, and candidacy is decided at an evaluation. That's exactly why cell-based therapy — widely searched as "stem cell therapy" — earns a serious look in the ankle.
Ankle arthritis is a different animal from knee or hip arthritis, and the patients are different too. Most ankle arthritis is post-traumatic — the late consequence of fractures and severe sprains years earlier. That means the patients are often in their 40s and 50s, active, and facing a surgical menu nobody loves: fuse the joint solid, or replace it at an age where a prosthesis may not outlast them.
That's exactly why cell-based therapy — widely searched as "stem cell therapy" — earns a serious look in the ankle. Here's the honest version of how it fits.
Why the ankle decision is so hard
The ankle carries more load per square inch than any other joint, through a very small surface. When its cartilage wears out, the pain is mechanical and relentless, and conservative options run out faster than in the knee:
Bracing and rocker-sole shoes help, but many patients tire of living in a boot-like brace
Cortisone injections give shorter relief with each repetition
Fusion (arthrodesis) reliably relieves pain but permanently eliminates ankle motion, shifting stress to the midfoot joints — a big trade at 45
Ankle replacement preserves motion but is generally reserved for older, lower-demand patients because of implant longevity
A younger, active patient with moderate ankle arthritis sits in a genuine gap in that menu. Regenerative treatment aims squarely at that gap.
What MFAT treatment involves
MFAT (microfragmented adipose tissue) starts with a small fat harvest from the flank or abdomen through a tiny poke-hole incision under local anesthetic. The tissue is processed to concentrate its cell-rich fraction and injected into the ankle joint under image guidance — precision matters enormously in a joint this small and tight.
The visit takes one to two hours, in the office. You'll leave in a walking boot for a short period to protect the joint, then transition back to regular shoes as we start rebuilding motion and strength.
What the evidence supports — and what it doesn't
Candor matters more in the ankle than almost anywhere, because the research is thinner:
Ankle-specific studies of cell-based therapy are small series, not large randomized trials. They report pain and function improvement for many patients with mild-to-moderate arthritis, consistent with what's seen in the knee — but the ankle evidence base is younger.
The strongest cell-therapy data overall is in the knee. Extrapolating to the ankle is reasonable but should be labeled as extrapolation.
Nothing regrows a worn-out ankle joint. The goal is a meaningful reduction in pain, better function, and delaying — ideally for years — a fusion or replacement decision.
If a clinic markets ankle stem cell therapy as proven to restore the joint, they're ahead of their data. We'd rather tell you what's known and what isn't, and let you decide with open eyes.
Who tends to be a good candidate?
Cell therapy for the ankle tends to fit patients who:
Have mild-to-moderate post-traumatic arthritis, confirmed on weight-bearing imaging
Still have reasonably preserved joint space and alignment — a badly tilted, deformed ankle is a mechanical problem biology can't correct
Have tried bracing, therapy, and injections without enough relief
Want to preserve ankle motion — often because of age, activity, or the work they do
Understand the evidence is promising rather than settled, and accept that framing
Poor fits include end-stage bone-on-bone arthritis with deformity, arthritis from uncontrolled inflammatory disease, and ankles whose main problem is instability from ligament failure that needs surgical stabilization first.
Recovery and expectations
Week 1: boot, relative rest, harvest-site soreness
Weeks 2–6: out of the boot progressively; physical therapy focused on motion, calf and peroneal strength, and balance — ankle rehab is not optional garnish, it's half the treatment
Months 2–6: the improvement window. Most responders judge the treatment in this period, not before
Avoid anti-inflammatory medications (like ibuprofen) for about two weeks afterward; we'll cover what's safe for soreness
The bottom line
For a 45-year-old with post-traumatic ankle arthritis, "fuse it or live with it" is an incomplete answer. Cell therapy offers a legitimate middle path — office-based, motion-preserving, and honestly framed: smaller evidence base than the knee, real reported benefit for the right patient, and no promises of a new joint.
If ankle pain from an old injury is narrowing your life, bring your imaging in. We'll grade the arthritis honestly and tell you whether you're a candidate — or whether the surgical conversation is the right one to have now.
Call 919.719.2270 to schedule an evaluation at our Raleigh or Cary office.
About Your Physicians
Dr. Matthew Kanaan
Nonsurgical Orthopedic Specialist
Founder of Carolina Nonsurgical Orthopedics. Fellowship trained in sports medicine at Duke; residency in family medicine at Duke, where he served as Chief Resident.
Dr. Pierce Knox
Nonsurgical Orthopedic Specialist
Fellowship trained in nonsurgical sports medicine at Penn Medicine; residency in primary care at Christiana Care.
